How should sertraline and bupropion be co‑prescribed, including starting doses, titration, safety monitoring for serotonin syndrome and seizure risk, and relevant contraindications?

Co-prescribing Sertraline and Bupropion

Sertraline and bupropion can be safely combined for treatment-resistant depression or to mitigate SSRI-associated sexual dysfunction, but requires careful monitoring for serotonin syndrome despite bupropion's minimal direct serotonergic activity, along with vigilance for seizure risk from bupropion.

Starting Doses and Titration

Initial Approach

When combining these medications, the sequence matters:

If starting sertraline first:

• Begin sertraline at 25-50 mg daily 1
• Titrate by 25-50 mg increments every 1-2 weeks as tolerated
• Maximum dose: 200 mg daily 1

If adding bupropion to existing sertraline:

• Start bupropion at 37.5 mg daily (or 150 mg sustained-release once daily) 1, 2
• Increase by 37.5 mg every 3 days for immediate-release 1
• For extended-release: start 150 mg daily for 3 days, then increase to 150 mg twice daily if tolerated 3, 2
• Maximum dose: 300 mg daily (150 mg twice daily) for immediate-release; 450 mg daily maximum for extended-release 2
• Critical timing: Give second dose before 3 PM to minimize insomnia risk 1

Dose Adjustments for Drug Interactions

Bupropion inhibits CYP2D6, which can increase sertraline levels 2. While sertraline has less effect on drug metabolism compared to other SSRIs 1, consider:

• Starting with lower sertraline doses when combining
• Slower titration intervals
• Monitoring for increased sertraline-related side effects (GI disturbances, tremor, sweating)

Safety Monitoring

Serotonin Syndrome Risk

Despite bupropion's primary action on dopamine/norepinephrine rather than serotonin, serotonin syndrome has been reported with this combination 4, 5, 6, 7. The mechanism likely involves bupropion's CYP2D6 inhibition increasing SSRI levels 4.

Monitor especially in the first 24-48 hours after starting combination or dose increases 8:

• Mental status changes: confusion, agitation, anxiety
• Neuromuscular hyperactivity: tremors, clonus (check ankle clonus), hyperreflexia, muscle rigidity
• Autonomic instability: hypertension, tachycardia (pulse >140), diaphoresis, hyperthermia, tachypnea
• GI symptoms: nausea, vomiting, diarrhea

Action if serotonin syndrome develops:

• Discontinue both medications immediately 8, 9
• Hospital-based supportive care with continuous cardiac monitoring 8
• Consider cyproheptadine (serotonin antagonist) 7

Seizure Risk Monitoring

Bupropion lowers seizure threshold in a dose-dependent manner 1, 3, 2:

Absolute contraindications for bupropion:

• Current seizure disorder 1, 3, 2
• History of bulimia or anorexia nervosa 2
• Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs 2
• Patients with brain metastases or stroke 3

Risk factors associated with seizures after bupropion use 10:

• Age 13-18 years (aOR 2.4)
• Tachycardia >140 bpm (aOR 1.9)
• QTc >500 ms (aOR 3.4)

Monitoring strategy:

• Baseline ECG to assess QTc interval
• Monitor heart rate at each visit
• Educate patients about seizure precautions
• Gradual dose escalation reduces seizure risk 2
• Maximum daily dose should not exceed 450 mg for extended-release or 400 mg for sustained-release 2

Additional Safety Considerations

Behavioral activation/agitation 9:

• More common early in treatment or with dose increases
• Monitor for motor restlessness, insomnia, impulsiveness, disinhibited behavior
• Can be misinterpreted as worsening depression
• Usually improves with dose reduction

Hypertension 11, 2:

• Check blood pressure before initiating and periodically during treatment
• Bupropion can increase blood pressure

Suicidality monitoring 9, 2:

• Increased risk in patients <25 years old
• Close monitoring especially in first months and after dose adjustments
• Educate families to report behavioral changes immediately

Contraindications and Drug Interactions

Absolute Contraindications

MAO inhibitors 8, 3, 9, 2:

• Do not use within 14 days of stopping an MAOI
• Do not start MAOI within 14 days of stopping sertraline or bupropion
• Includes linezolid and IV methylene blue
• Risk: hypertensive crisis and severe serotonin syndrome

Relative Contraindications and Cautions

For bupropion specifically:

• Closed-angle glaucoma 3
• Concurrent tamoxifen use 3
• Severe hepatic impairment: reduce to 150 mg every other day 2
• Moderate hepatic impairment: consider dose/frequency reduction 2
• Renal impairment: consider dose/frequency reduction 2

For sertraline:

• Citalopram or drugs prolonging QT interval (additive effects) 8

Other Serotonergic Drugs to Avoid or Use Cautiously

When patients are on sertraline + bupropion, exercise extreme caution with 8, 9:

• Tramadol, fentanyl, meperidine, methadone (opioids)
• Dextromethorphan (cough suppressants)
• Triptans (migraine medications)
• St. John's Wort, L-tryptophan
• Amphetamines, methylphenidate
• Cocaine, MDMA, methamphetamine

Clinical Efficacy Evidence

The combination is generally well-tolerated and effective 12, 13:

• 70% of patients showed greater improvement with combination vs. monotherapy 13
• Effective for treatment-resistant depression 14, 12
• Reduces SSRI-associated sexual dysfunction 12
• Similar adverse effect profile to monotherapy when dosed conservatively 12, 13

Common adverse effects with combination 13:

• Sexual dysfunction: 41%
• Insomnia: 22%
• Anergy: 15%
• Tremor: 11%

Discontinuation Strategy

When stopping either medication:

• Taper over 10-14 days to minimize withdrawal symptoms 1
• Sertraline has higher risk of discontinuation syndrome (dizziness, paresthesias, anxiety, GI symptoms) 8
• Bupropion can be discontinued more abruptly but gradual taper preferred

Key Clinical Pitfalls

1. Misinterpreting early serotonin syndrome as depression worsening 4: Early myoclonus, confusion, and agitation may prompt clinicians to add more serotonergic agents, worsening the syndrome

2. Overlooking seizure risk factors: Always screen for eating disorders, alcohol use, and seizure history before prescribing bupropion 2

3. Inadequate patient education: Patients must understand to report tremors, confusion, fever, or muscle rigidity immediately

4. Timing errors: Second bupropion dose after 3 PM increases insomnia risk 1

5. Drug interaction blindness: Bupropion's CYP2D6 inhibition affects multiple medications beyond sertraline (antipsychotics, beta-blockers, other antidepressants) 2

1, 8, 3, 9, 2, 12, 4, 13, 5, 7, 10